Bumrungrad Hospital Public Company Limited (SET: BH) has announced its 1Q25 consolidated financial statement through the Stock Exchange of Thailand as follows:
| Quarter | 1Q25 | 1Q24 |
| Net Profit (Loss) Million Baht |
1,733.83 | 1,984.84 |
| Earning Per Share (Baht) |
2.1800 | 2.5000 |
| % Change | -12.65 | |
BH reported a net profit of Baht 1,734 million in 1Q25, a 12.65% drop from the same period of last year. The company reported total revenues of Baht 6,208 million for 1Q25, a 5.6% decrease from Baht 6,576 million in 1Q24. Meanwhile, net profit margin was 27.9% for 1Q25, compared to 30.2% in 1Q24.
The decrease in revenue was primarily due to a 9.7% decrease in revenue from non-Thai patients, highly correlated to the greater impact of Ramadan days experienced in 1Q25 compared to 1Q24.
Cost of hospital operations (including Depreciation and amortization) was Baht 3,040 million in 1Q25, reflecting a 3.4% decrease from Baht 3,146 million in 1Q24. The variance was mostly due to Baht 77 million decrease in doctor fees and Baht 20 million decrease in supply costs. The percentage of cost to revenues from hospital operations was 49.7% in 1Q25, compared to 48.3% in 1Q24.
EBITDA decreased by 12.6% year-over-year to Baht 2,338 million in 1Q25 from Baht 2,676 million in 1Q24, with an EBITDA margin of 37.7% in 1Q25 compared to 40.7% in 1Q24.
